Consumer group: FDA must ban Avandia because of health risks

10/30/2008 | Washington Post (tiered subscription model), The

Public Citizen, a consumer-advocacy group, called on the FDA to ban GlaxoSmithKline's Avandia because of life-endangering risks, including heart attack and liver failure, linked to the diabetes drug. The agency said it will "carefully review" the petition, which comes after the American Diabetes Association issued revised treatment guidelines that advise against Avandia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT